Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

34.31
BATS BZX Real-Time Price
As of 2:52pm ET
 +0.015 / +0.04%
Today’s Change
26.97
Today|||52-Week Range
34.88
+1.05%
Year-to-Date
AstraZeneca (AZN) Beats on Q2 Earnings, Keeps 2016 View
9:50am / Zacks.com - Paid Partner Content
Analysts' Actions -- GE, Nordstrom, Rockwell Collins, Sprint and More
Jul 26 / TheStreet.com - Paid Partner Content
AstraZeneca (AZN) Stock Up After Q2 Earnings, Revenue Beat
Jul 28 / TheStreet.com - Paid Partner Content
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Leading In Pre-Market Activity
Jul 28 / TheStreet.com - Paid Partner Content
European Stock Markets Mixed After Signs of Brexit Damage
Jul 22 / TheStreet.com - Paid Partner Content
AstraZeneca Earnings, Sales Edge Above Forecasts
Jul 28 / TheStreet.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
3 Stocks Boosting The Health Care Sector Higher
Jul 27 / TheStreet.com - Paid Partner Content
Why Shares of Relypsa Are Soaring Today
Jul 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close34.29
Today’s open33.75
Day’s range33.48 - 34.32
Volume794,113
Average volume (3 months)4,999,847
Market cap$79.8B
Dividend yield4.08%
Data as of 2:52pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-6.91%
Earnings growth (next 5 years)+0.75%
Revenue growth (last year)-5.11%
P/E ratio29.8
Price/Sales3.48
Price/Book4.31

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+0.72+0.65%
LLYEli Lilly and Co+0.05+0.06%
ABTAbbott Laboratories+0.24+0.54%
SHPGShire+2.31+1.21%
Data as of 2:52pm ET, 07/29/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts

Partner Offers

Search for Jobs